West Pharmaceutical Services, Inc. splits its revenue 2 ways in its filings. By operating segments, the largest line in fiscal 2025, which ended Dec 31, 2025 was Proprietary Products at $2.5 billion, 81% of the total. By sales mix, the largest line in fiscal 2025, which ended Dec 31, 2025 was Proprietary Products at $2.5 billion, 81% of the total.
USD in millions. The percent under a figure is the change from the year before.
| Line |
FY 2026
Sep 30, 2026
|
FY 2025
Dec 31, 2025
|
FY 2024
Dec 31, 2024
|
FY 2023
Dec 31, 2023
|
FY 2022
Dec 31, 2022
|
FY 2021
Dec 31, 2021
|
FY 2020
Dec 31, 2020
|
FY 2019
Dec 31, 2019
|
FY 2018
Dec 31, 2018
|
FY 2017
Dec 31, 2017
|
FY 2016
Dec 31, 2016
|
|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue |
3,397
|
3,074
|
2,893
|
2,950
|
2,887
|
2,832
|
2,147
|
1,840
|
1,717
|
1,599
|
1,509
|
| Operating segments | |||||||||||
| Proprietary Products |
2,808
+14.9%
share 82.7%
|
2,492
+6.8%
share 81.1%
|
2,334
-2.6%
share 80.7%
|
2,397
share 81.3%
|
—
|
—
|
—
|
1,399
+6.9%
share 76.0%
|
1,309
+5.8%
share 76.2%
|
1,237
share 77.3%
|
—
|
| West Vantage |
589
+2.7%
share 17.3%
|
582
+4.2%
share 18.9%
|
559
+1.1%
share 19.3%
|
552
share 18.7%
|
—
|
—
|
—
|
442
+7.9%
share 24.0%
|
409
+12.9%
share 23.8%
|
362
share 22.7%
|
—
|
| Sales mix | |||||||||||
| Proprietary Products |
2,808
+14.9%
share 82.7%
|
2,492
+6.8%
share 81.1%
|
2,334
-2.6%
share 80.7%
|
2,397
share 81.3%
|
—
|
—
|
—
|
1,399
+6.9%
share 76.0%
|
1,309
+5.8%
share 76.2%
|
1,237
share 77.3%
|
—
|
| West Vantage |
589
+2.7%
share 17.3%
|
582
+4.2%
share 18.9%
|
559
+1.1%
share 19.3%
|
552
share 18.7%
|
—
|
—
|
—
|
442
+7.9%
share 24.0%
|
409
+12.9%
share 23.8%
|
362
share 22.7%
|
—
|
How these figures are calculated
Annual columns are full-year amounts from the annual report (Form 10-K, 20-F, or 40-F). If a company restates a year, the latest filed number is shown. USD in millions. Each group is a separate split of total revenue, so the groups are not added together. Share of revenue is that line divided by total revenue. The first column adds the latest year-to-date segment amount to the last fiscal year and subtracts the year-ago year-to-date amount. More on our methodology.
Company profile
- Industry
- Surgical & Medical Instruments & Apparatus (SIC 3841)
- Listed as
- WST (NYSE)
- Fiscal year ends
- December 31
- Incorporated in
- PA
- Headquarters
- Exton, PA
- SEC filer status
- Large accelerated filer
- SEC CIK
- 105770
- Former names
- WEST CO INC (until Feb 11, 1999)
Other Surgical & Medical Instruments & Apparatus companies
- Stryker Corp SYK
- 3M Co MMM
- Boston Scientific Corp BSX
- Becton Dickinson & Co BDX
- Medline Inc. MDLN
- Resmed Inc RMD
- Dexcom Inc DXCM
- Fresenius SE & Co. KGaA FSNUY
All 151 Surgical & Medical Instruments & Apparatus companies
Source: SEC EDGAR filings. This is company-reported data, not investment advice.